← FDA Drug Approvals (Drugs@FDA)

REVEFENACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN INC. · Approved 2026-05-15

Drug application

FDA Application #

ANDA218088

Application type

Abbreviated New Drug Application (Generic)

Brand name

REVEFENACIN

Generic name

Revefenacin

Active ingredients

REVEFENACIN

Dosage form

SOLUTION

Route

—

Marketing status

None (Tentative Approval)

Sponsor

LUPIN INC.

First approval

2026-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown